Theratechnologies (NASDAQ:THTX) Stock

Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Theratechnologies Inc

Barclays analyst Jeffrey Bernstein maintains US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) with a Overweight and raises the price target from $85 to $95.

News

Price Target

Analyst Ratings

USFD

Barclays Maintains Overweight on US Foods Hldg, Raises Price Target to $95

B of A Securities analyst Lisa Lewandowski maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $182 to $200.

B of A Securities Maintains Buy on Philip Morris Intl, Raises Price Target to $200

B of A Securities analyst Lorraine Hutchinson maintains Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) with a Neutral and raises the price target from $65 to $78.

B of A Securities Maintains Neutral on Signet Jewelers, Raises Price Target to $78

B of A Securities analyst Lawson Winder initiates coverage on Centrus Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LEU#AMEX">LEU</a>) with a Buy rating and announces Price Target of $160.

Initiation

B of A Securities Initiates Coverage On Centrus Energy with Buy Rating, Announces Price Target of $160

Barclays analyst Raimo Lenschow maintains Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Equal-Weight and raises the price target from $96 to $100.

PEGA

Barclays Maintains Equal-Weight on Pegasystems, Raises Price Target to $100

B of A Securities analyst Erika Najarian maintains Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) with a Buy and raises the price target from $83 to $90.

B of A Securities Maintains Buy on Wells Fargo, Raises Price Target to $90

ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>),&nbsp; a leading innovator in advanced security screening technologies, today announced that it has secured a formal allocation to complete the European Civil Aviation Conference (ECAC) certification process for its advanced Sentinel Fixed-Gantry CT system, designed for high-accuracy explosive detection in aviation environments.
This allocation positions the Company to undergo additional Phase testing under ECAC's Common Evaluation Process of Security Equipment (CEP), a critical step toward achieving European approval for deployment at airports across the European Union and beyond.

STAI

ScanTech AI Systems Secures Formal Allocation To Complete ECAC Certification Process For Advanced Sentinel Fixed-Gantry CT System

B of A Securities analyst Tal Liani downgrades CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from Buy to Neutral and raises the price target from $420 to $470.

Downgrades

CRWD

B of A Securities Downgrades CrowdStrike Holdings to Neutral, Raises Price Target to $470

Barclays analyst Tim Long maintains Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) with a Overweight and raises the price target from $20 to $24.

Barclays Maintains Overweight on Hewlett Packard, Raises Price Target to $24

Crypto projects linked to President Donald Trump's family are making notable moves, and traders are watching closely. Recent token transfers to major exchanges are fueling speculation that something bigger may be unfolding behind the scenes.
What Happened: According to Spot On Chain, multiple wallets <a href="https://x.com/spotonchain/status/1930103423741112746">associated</a> with Trump-related crypto initiatives made significant transactions on June 4:
<ul class="wp-block-list">
<li>The MELANIA team transferred 20 million MELANIA (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MELANIA</a>) tokens (valued at $6.62 million) to Wintermute, following the announcement of a market-making partnership.</li>
<li>Just hours later, a wallet tied to the OFFICIAL TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) token deposited 4.17 million tokens worth $46.97 million to Binance, OKX, Coinbase, and Bybit.</li>
<li>Meanwhile, World Liberty Financial airdropped 47 units of its USD1 stablecoin to participants in its WLFI sale — distributing a total of $4 million.</li>
</ul>
These coordinated moves to exchanges have sparked debate on Crypto Twitter, with some speculating that insiders may have knowledge of imminent news or listings.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45626262/trump-meme-coin-dinner-turned-into-high-net-worth-crypto-networking-trump-was-there-for-20-minutes">TRUMP Meme Coin Dinner Turned Into High-Net-Worth Crypto Networking: &#8216;Trump Was There For 20 Minutes&#8217;</a>
Why It Matters: The Melania Meme Coin <a href="https://x.com/TrueMELANIAmeme/status/1929973793931379184">confirmed</a> its partnership with Wintermute, a leading crypto liquidity provider. This collaboration is expected to boost MELANIA&#8217;s liquidity and potentially its volatility, making it a hot watch for short-term traders and institutional players.
In contrast, Donald Trump Jr. and Eric Trump have <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45757170/trump-branded-crypto-wallet-sparks-controversy-trump-family-denies-involvement">publicly denied any involvement</a> in the TrumpWallet.com project, despite its branding as the "first and only crypto wallet for true Trump fans."
Further raising eyebrows, Dune Analytics <a href="https://dune.com/seoul/usd1">data</a> shows extreme centralization in World Liberty's USD1 stablecoin, with one wallet holding 47.5%, another 36.9%, and a third 9.5%. This skewed distribution could pose risks to price stability and investor trust.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45767169/bitcoin-ethereum-xrp-dogecoin-tick-up-as-battle-for-105000-intensifies">Bitcoin, Ethereum, XRP, Dogecoin Tick Up As &#8216;Battle For $105,000&#8217; Intensifies</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$MELANIA

$TRUMP

Trump-Linked Crypto Tokens Flood Exchanges — Is A Major Move On The Horizon?

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has invested, through <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.accenture.com%2Fus-en%2Fabout%2Fventures-index&amp;esheet=54264828&amp;newsitemid=20250604091769&amp;lan=en-US&amp;anchor=Accenture+Ventures&amp;index=1&amp;md5=6a4ef4532421fbe19e44428cefe6e0c0">Accenture Ventures</a>, in <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.reserv.com%2F&amp;esheet=54264828&amp;newsitemid=20250604091769&amp;lan=en-US&amp;anchor=Reserv&amp;index=2&amp;md5=f05f3a817d1da0ecd07a08d499045fdd">Reserv</a>, an insurance claims processing company that complements deep claims expertise with innovative AI-driven solutions. The investment will also enable the two companies to collaborate on solutions that increase accuracy and efficiency throughout the claims ecosystem, helping underwriters and claims professionals deliver better outcomes and service experiences for claimants.
As a third-party administrator (TPA), Reserv provides claims services for property &amp; casualty (P&amp;C) insurers across the United States and the U.K. Reserv's services use data warehouse, analytics, and generative AI capabilities to automate background processes and increase agility, allowing claims professionals to focus on accuracy and improving customer experience.
Terms of the investment were not disclosed.
 &nbsp;
 &nbsp;

Accenture Invests In Reserv To Advance AI-Driven Insurance Claims Solutions; Investment Terms Not Disclosed

WIIM

Wells Fargo shares are trading higher following its announcement that it's no longer subject to asset growth restrictions that were imposed in 2018.

B of A Securities analyst Robert Ohmes maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Buy and raises the price target from $115 to $135.

B of A Securities Maintains Buy on Dollar General, Raises Price Target to $135

Introducing a simplified ride experience designed for older adults
Introducing a simplified ride experience designed for older adults

UBER

Uber Launches Nationwide Senior Accounts Feature To Simplify Ride Experience For Older Adults With Streamlined App Interface, Optional Family Support, And New "Simple Mode" For Independent Use

Barclays analyst Matthew Bouley maintains Ferguson Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) with a Overweight and raises the price target from $190 to $247.

FERG

Barclays Maintains Overweight on Ferguson Enterprises, Raises Price Target to $247

SGMT

Sagimet Biosciences shares are trading higher after the company announced its Phase 3 Denifanstat acne therapy clinical trial met all primary and secondary endpoints.

Baird analyst Joe Vruwink maintains ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) with a Outperform and raises the price target from $106 to $124.

TTAN

Baird Maintains Outperform on ServiceTitan, Raises Price Target to $124

Barclays analyst Karen Short maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Overweight and raises the price target from $100 to $119.

Barclays Maintains Overweight on Dollar General, Raises Price Target to $119

ENSC

ENSC stock has given up its prior gain. Ensysce Biosciences shares were trading higher after the company announced it was awarded the second $5.3 million installment of a $15 million, three-year grant from the National Institute on Drug Abuse.

SXTP

60 Degrees Pharmaceuticals shares are trading higher after the company launched a new bottle format of ARAKODA.

Press Releases

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment

Earnings

Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update

Health Care

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

Comments

Theratechnologies

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL